Compare OGE & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGE | BAX |
|---|---|---|
| Founded | 1902 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.2B |
| IPO Year | 2009 | 1994 |
| Metric | OGE | BAX |
|---|---|---|
| Price | $49.37 | $19.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 9 |
| Target Price | ★ $47.33 | $22.38 |
| AVG Volume (30 Days) | 1.5M | ★ 9.6M |
| Earning Date | 05-21-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.46% | 0.20% |
| EPS Growth | ★ 5.94 | N/A |
| EPS | ★ 2.32 | N/A |
| Revenue | $3,260,100,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $2.45 | $1.83 |
| Revenue Next Year | $0.96 | $2.28 |
| P/E Ratio | $21.16 | ★ N/A |
| Revenue Growth | ★ 9.21 | 5.72 |
| 52 Week Low | $40.80 | $17.40 |
| 52 Week High | $49.18 | $37.74 |
| Indicator | OGE | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 83.40 | 43.31 |
| Support Level | $42.94 | $18.53 |
| Resistance Level | N/A | $24.37 |
| Average True Range (ATR) | 1.02 | 0.91 |
| MACD | 0.28 | -0.18 |
| Stochastic Oscillator | 97.05 | 27.64 |
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.